Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.36 USD | +4.69% | +5.51% | +42.55% |
May. 28 | CorMedix Shares Rise on Multiyear DefenCath Supply Deal | MT |
May. 28 | CorMedix Inc. Announces Commercial Agreement with Top Tier Dialysis Provider | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.55% | 295M | |
+16.34% | 79.28B | |
+8.35% | 8.74B | |
-16.33% | 4.84B | |
+51.22% | 4.74B | |
+2.18% | 3.87B | |
+20.51% | 2.46B | |
-26.79% | 2.18B | |
+15.12% | 2.09B | |
-36.56% | 1.98B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- RBC Initiates CorMedix at Outperform, Speculative Risk With $6 Price Target, Sees DefenCath 'More Likely Than Not to Be Approved'